Latin America & the Caribbean (IDA & IBRD countries) | Immunization, measles (% of children ages 12-23 months)
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Latin America & the Caribbean (IDA & IBRD countries)
Records
63
Source
Latin America & the Caribbean (IDA & IBRD countries) | Immunization, measles (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980 41.96735028
1981 48.76957886
1982 48.4897493
1983 47.00106058
1984 51.47780123
1985 59.66162895
1986 60.90988842
1987 59.74799286
1988 65.33756282
1989 68.86244349
1990 75.61168581
1991 80.03770059
1992 82.3798739
1993 81.86131468
1994 82.23554839
1995 86.00257591
1996 83.9157626
1997 88.54260162
1998 90.77986048
1999 92.10385253
2000 93.51521134
2001 94.69532056
2002 93.47252519
2003 93.90594877
2004 92.97014123
2005 92.61354488
2006 94.36639292
2007 94.04597223
2008 94.90736553
2009 94.53799216
2010 93.41599906
2011 94.50716337
2012 95.20285436
2013 91.79115308
2014 92.72250914
2015 93.06346967
2016 92.48667832
2017 86.1755954
2018 91.13001273
2019 86.0581018
2020 82.82054999
2021 81.65605105
2022 81.06373899
Latin America & the Caribbean (IDA & IBRD countries) | Immunization, measles (% of children ages 12-23 months)
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Latin America & the Caribbean (IDA & IBRD countries)
Records
63
Source